By Sean Moloughney, Editor03.19.19
Canadian biotech company Rapid Dose Therapeutics (RDT) is looking to revolutionize how consumers and patients take nutraceuticals and therapeutic products through its proprietary delivery system branded as QuickStrip.
QuickStrip is a thin film made from a soluble polymer that can be embedded with active ingredients, said Kristina Shea, marketing and communications director with RDT. “Our proprietary technology micronizes the active ingredient droplets so the active ingredient is delivered through the oral mucosa tissue.”
Quickstrip is taken on or under the tongue, which is preferred, or inside the cheek. “As the film contacts saliva in the mouth it begins to dissolve instantly and is completely dissolved within seconds of placement on or under the tongue and oral mucosa,” said Shea. “The active ingredient is then delivered quickly to the bloodstream by diffusing through pores in the mouth.”
This offers the consumer a faster pathway to the desired effect of the active ingredient since it directly enters the bloodstream, bypassing the digestive system
QuickStrip is a thin film made from a soluble polymer that can be embedded with active ingredients, said Kristina Shea, marketing and communications director with RDT. “Our proprietary technology micronizes the active ingredient droplets so the active ingredient is delivered through the oral mucosa tissue.”
Quickstrip is taken on or under the tongue, which is preferred, or inside the cheek. “As the film contacts saliva in the mouth it begins to dissolve instantly and is completely dissolved within seconds of placement on or under the tongue and oral mucosa,” said Shea. “The active ingredient is then delivered quickly to the bloodstream by diffusing through pores in the mouth.”
This offers the consumer a faster pathway to the desired effect of the active ingredient since it directly enters the bloodstream, bypassing the digestive system
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
